Drugmakers uninterested in Trump's order to split up MMR vaccine
The Hill · 79 days ago
President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive.
Continue reading at The Hill →Related
Trump says he has 'every intention' to keep Hegseth
ABC News · 8 minutes ago
Pete Hegseth may take fall for Republicans’ midterm losses, despite Trump support
The Guardian · 15 hours ago
Hakeem Jeffries Says Impeachment and Getting Even Aren’t Priorities
The New Republic · 1 day ago
In the Midterms, America Rebuked Trump’s Authoritarianism
Jacobin · 1 day ago
